Skip to main content

Table 3 Correlation between clinical parameters and CYFRA21-1

From: Evaluation of the value of preoperative CYFRA21-1 in the diagnosis and prognosis of epithelial ovarian cancer in conjunction with CA125

Clinical characteristicsNo.CYFRA21-1
Median (IQR25–75)
P value
All2035.26 (1.27–5.24) 
Age  0.062
 < 55 years1111.75 (0.97–3.85) 
 ≥ 55 years922.68 (1.58–6.67) 
Menopause  0.059
 Yes1151.82 (1.13–4.66) 
 No882.34 (1.42–5.96) 
Tumor size  0.8714
 < 5 cm761.96 (1.22–5.79) 
 ≥ 5 cm1272.20 (1.29–5.03) 
Subtype   
 Serous1442.43 (1.40–6.01)0.0547
 Mucinous161.55 (0.96–1.89) 
 Endometrioid241.89 (1.09–4.38) 
 Clear cell151.49 (0.99–2.51) 
 M/R41.97 (1.71–2.25) 
Grade  0.000*
 1340.99 (0.79–1.76) 
 2371.41 (1.06–2.11) 
 31322.795 (1.38–11.12) 
Stage  0.000*
 I334.05 (0.86–3.99) 
 II692.94 (1.08–2.43) 
 III529.29 (1.17–9.76) 
 IV498.31 (2.24–10.72) 
Lymph node  0.000*
 Yes655.07 (2.23–11.80) 
 No1381.33 (0.77–2.67) 
Ascites  0.000*
 Yes295.79 (1.97–7.90) 
 No1741.50 (0.80–4.07) 
  1. *P < 0.05